RG-6319

N/A

Report date: 2022/07/13 16:52:02
NME

Base Information

Drug NameRG-6319
Drug Alias NameRG-6319
ClassificationOther
Mechanisms of Actiontype I signal peptidase inhibitors
Targetstype I signal peptidase
Therapy Area/IndicationsUrinary Tract Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesF. Hoffmann-La Roche LtdGenentech Inc
Inactive CompaniesN/A
Active IndicationsUrinary Tract Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A